KETANSERIN VERSUS PLACEBO IN CARCINOID-SYNDROME - A CLINICAL CONTROLLED TRIAL

被引:45
作者
GUSTAFSEN, J [1 ]
LENDORF, A [1 ]
RASKOV, H [1 ]
BOESBY, S [1 ]
机构
[1] RIGSHOSP,SURG GASTROENTEROL DEPT C,9 BLEGDAMSVEJ,DK-2100 COPENHAGEN O,DENMARK
关键词
D O I
10.3109/00365528609011123
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:816 / 818
页数:3
相关论文
共 16 条
[1]  
FROHLICH JC, 1978, NEW ENGL J MED, V299, P1055
[2]  
GRAHAMESMITH DG, 1978, ENDOCRINOLOGY, V3, P1721
[3]  
HAKANSON R, 1977, SUBSTANCE P, P55
[4]   5-HYDROXYTRYPTAMINE IN A CARCINOID TUMOUR [J].
LEMBECK, F .
NATURE, 1953, 172 (4385) :910-911
[5]   RECEPTOR-BINDING PROFILE OF R-41-468, A NOVEL ANTAGONIST AT 5-HT2 RECEPTORS [J].
LEYSEN, JE ;
AWOUTERS, F ;
KENNIS, L ;
LADURON, PM ;
VANDENBERK, J ;
JANSSEN, PAJ .
LIFE SCIENCES, 1981, 28 (09) :1015-1022
[6]  
LUDVIG CD, 1968, ANN INTERN MED, V68, P1188
[7]  
MELMON KL, 1965, GASTROENTEROLOGY, V48, P18
[8]   ANTISERA RAISED AGAINST ELEDOISIN AND KASSININ DETECT ELEVATED LEVELS OF IMMUNOREACTIVE MATERIAL IN PLASMA AND TUMOR-TISSUES FROM PATIENTS WITH CARCINOID-TUMORS [J].
NORHEIM, I ;
THEODORSSONNORHEIM, E ;
BRODIN, E ;
OBERG, K ;
LUNDQVIST, G ;
ROSELL, S .
REGULATORY PEPTIDES, 1984, 9 (04) :245-257
[9]  
Oates J A, 1967, Adv Pharmacol, V5, P109, DOI 10.1016/S1054-3589(08)60656-0
[10]   EVIDENCE FOR RELEASE OF BRADYKININ IN CARCINOID SYNDROME [J].
OATES, JA ;
PETTINGER, WA ;
DOCTOR, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (02) :173-+